糖酸激酶的多元化:探索正规,月光和瘤微环境功能的探索
Han-Hsi Kuo1, Zhao-Jing He1, Phi Ngoc Tram2
1Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Biochimica et biophysica acta. Molecular basis of disease
|October 16, 2025
概括
糖酸酶 (PGK) 蛋白在癌症中具有非酶作用,影响瘤进展和瘤微环境. 针对这些"月光"功能提供了新的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 糖酸酶 (PGK) 家族成员,PGK1和PGK2,是已知的甘油酶.
- 新出现的证据揭示了PGK1和PGK2的各种非酶的"月光"功能.
- 这些功能在癌症生物学中至关重要,影响信号传递,细胞外基质,免疫力和转移.
研究的目的:
- 重新评估PGKs在瘤进展和瘤微环境 (TME) 中的月光功能.
- 突出PGKs在细胞外信号传递,应激适应和免疫逃避中的作用.
- 整合新的PGKs的翻译后修改.
主要方法:
- 对PGK功能超出正规糖解的现有文献的综述.
- 对专注于PGK在瘤微环境中的作用的研究进行分析.
- 整合关于PGKs翻译后修改的数据.
主要成果:
- 在TME中,PGK1和PGK2表现出取决于上下文的,空间组织的功能.
- 这些蛋白质作为压力传感器和免疫反应的调节者.
- 证据支持它们参与细胞外信号传递和免疫逃避.
结论:
- PGKs具有显著的非酶性,促进癌症的活动.
- 针对这些月光功能的治疗提供了新的治疗机会.
- 了解PGK的多方面的作用对于癌症治疗策略至关重要.
更多相关视频
相关概念视频
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Protein Kinases and Phosphatases
14.8K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.8K
Protein Kinases and Phosphatases
4.3K
4.3K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


